The latest immunotherapy news and developments
Drug combo breaks down cancer resistance to immunotherapy
Immunotherapy is a way of treating cancer by reprogramming the patient’s immune system to attack…
Browsing: Immunotherapy
Scientists develop a cancer vaccine to simultaneously kill and prevent brain cancer
Scientists are harnessing a new way to turn cancer cells into potent, anti-cancer agents. In…
Researchers use zebrafish to study a cancer-linked inflammation pathway
In science, how you ask a question is often as important as what you ask.…
World’s first clinical trial with CAR-T technology for patients with T-cell leukaemia subtype authorised
The Spanish Agency of Medicines and Medical Products (AEMPS) has approved the CARxALL clinical trial…
Why don’t T cells destroy solid tumours during immunotherapy?
The great hope of cancer immunotherapy is to bolster our own immune cells in specific…
Bioengineered synthetic gene circuits enhance cancer immunotherapies
In two separate studies, researchers demonstrate how synthetic biology can be used to tackle a difficult…
ASH 2022: Researchers present new approach to understanding challenging CAR T-cell toxicities
During the 64th annual meeting of the American Society of Hematology (ASH), held December 10-13…
Fighting cancer is more efficient at dawn
The ability of tumours to take hold and grow depends, among other things, on the…
New technology for inhibiting T cell exhaustion and reinvigorating exhausted T cells, which is essential for immune cell therapy of solid cancer
Professor Rho Hyun Seong and researcher Jinwoo Na of Seoul National University’s School of Life…
Experimental cancer vaccine shows promise in animal studies
An experimental therapeutic cancer vaccine induced two distinct and desirable immune system responses that led…